Concepedia

Nina Ilić

NI

Statistics

Publications

16

Citations

1.6K

H-Index

16

Active since

2008

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Mater Health Services

Broad Institute

The University of Queensland

Nina Ilić is an author at Dana-Farber Cancer Institute specializing in medicine, molecular oncology, and oncology.

Publications per year

2008–2021

16

Publications

16

A phase 1b study of placenta‐derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis

Daniel C. Chambers, D. Enever, Nina Ilić et al. · Respirology · 2014 · 290 citations

Medicine, Cell Biology, Pathobiology +16

PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis

Nina Ilić, Tamara Utermark, Hans R. Widlund et al. · Proceedings of the National Academy of Sciences · 2011 · 210 citations · Full text

Medicine, Oncology, Pharmacology +17

Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles

Eejung Kim, Nina Ilić, Yashaswi Shrestha et al. · Cancer Discovery · 2016 · 187 citations · Full text

Medicine, Genetics, Oncology +17

KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

Elsa Krall, Belinda Wang, Diana M. Muñoz et al. · eLife · 2017 · 158 citations · Full text

Medicine, Cancer Biology, Oncology +17

Manufacturing of human placenta‐derived mesenchymal stem cells for clinical trials

Gary Brooke, Tony Rossetti, Rebecca Pelekanos et al. · British Journal of Haematology · 2008 · 155 citations

Life Sciences, Biotechnology, Cell Biology +17

1–5 of 16